Search Results - "KNOBLER, Robert"
-
1
Extracorporeal Photopheresis-An Overview
Published in Frontiers in medicine (27-08-2018)“…Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after receiving FDA approval for the palliative treatment of the Sézary…”
Get full text
Journal Article -
2
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Published in Journal of clinical oncology (20-06-2011)“…Mycosis fungoides (MF) and Sézary syndrome (SS), the major forms of cutaneous T-cell lymphoma, have unique characteristics that distinguish them from other…”
Get full text
Journal Article Conference Proceeding -
3
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Published in Blood (13-10-2011)“…Primary cutaneous CD30+ lymphoproliferative disorders (CD30+ LPDs) are the second most common form of cutaneous T-cell lymphomas and include lymphomatoid…”
Get full text
Journal Article -
4
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Published in Blood (15-09-2007)“…The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group classification and staging system for cutaneous T-cell lymphoma (CTCL). These…”
Get full text
Journal Article -
5
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
Published in Blood (01-10-2008)“…Chronic graft-versus-host disease (cGVHD) is a major limitation of successful hematopoietic cell transplantation. The safety and efficacy of extracorporeal…”
Get full text
Journal Article -
6
Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012
Published in Journal of clinical oncology (20-11-2012)“…Mycosis fungoides (MF) is the most common primary cutaneous T-cell lymphoma. There is a need for multicenter trials involving defined patient populations using…”
Get full text
Journal Article -
7
A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation
Published in The Journal of heart and lung transplantation (01-09-2012)“…Background The aim of this prospective study was to evaluate the efficacy and safety of extracorporeal photopheresis (ECP) in patients with bronchiolitis…”
Get full text
Journal Article -
8
Patients' Illness Perception as a Tool to Improve Individual Disease Management in Primary Cutaneous Lymphomas
Published in Acta dermato-venereologica (07-02-2018)“…The Revised Illness Perception Questionnaire (IPQ-R) has been shown to assess illness perception reproducibly in primary cutaneous T-cell lymphomas (CTCL)…”
Get full text
Journal Article -
9
Recent advances in understanding and managing cutaneous T-cell lymphomas [version 1; peer review: awaiting peer review]
Published in F1000 research (2020)“…Cutaneous T-cell lymphomas (CTCLs) comprise a heterogeneous group of extranodal non-Hodgkin lymphomas involving primarily the skin and mycosis fungoides is its…”
Get full text
Journal Article -
10
Extracorporeal photopheresis: Past, present, and future
Published in Journal of the American Academy of Dermatology (01-10-2009)“…Extracorporeal photopheresis (ECP) is a leukapheresis-based therapy that uses 8-methoxypsoralen and ultraviolet A irradiation. Used alone or in combination…”
Get full text
Journal Article -
11
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
Published in Frontiers in immunology (17-02-2023)“…Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant haematological diseases. Despite continuous improvements in pre- and…”
Get full text
Journal Article -
12
The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease
Published in Haematologica (Roma) (01-03-2006)“…Medical University of Vienna, Department of Internal Medicine I, Bone Marrow Transplantation, Austria. hildegard.greinix@meduniwien.ac.at Acute…”
Get full text
Journal Article -
13
Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure
Published in Haematologica (Roma) (01-11-2014)“…Second-line therapy for corticosteroid-refractory or -dependent acute graft-versus-host disease remains ill-defined, due to limited efficacy of drugs and…”
Get full text
Journal Article -
14
High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas
Published in Journal of dermatological science (01-12-2011)“…Abstract Background Aberrant expression of microRNAs (miRNAs) has been implicated in oncogenesis of various tumors and primary cutaneous T cell lymphomas…”
Get full text
Journal Article -
15
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
Published in Journal of the American Academy of Dermatology (01-05-2006)“…Systemic sclerosis is a multisystemic connective tissue disease with marked involvement of the skin and joints for which few effective evidence based therapies…”
Get full text
Journal Article -
16
Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group
Published in Journal of the American Academy of Dermatology (01-09-2002)“…Radiotherapy has been successfully implemented in the treatment of mycosis fungoides (MF) for almost a century. With the development of the modern linear…”
Get full text
Journal Article -
17
Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study
Published in Blood (01-10-2000)“…Extracorporeal exposure of peripheral blood mononuclear cells to the photosensitizing agent 8-methoxypsoralen and UV-A radiation has been shown to be effective…”
Get full text
Journal Article -
18
Skin Hyperpigmentation in Complex Regional Pain Syndrome (CRPS) (P3.315)
Published in Neurology (06-04-2015)“…Abstract only…”
Get full text
Journal Article -
19
Extracorporeal Photopheresis versus Anticytokine Therapy as a Second-Line Treatment for Steroid-Refractory Acute GVHD: A Multicenter Comparative Analysis
Published in Biology of blood and marrow transplantation (01-07-2013)“…Abstract The optimal therapy for steroid-refractory (SR) acute graft-versus-host disease (aGVHD) is undefined. We studied patients with SR aGVHD, comparing…”
Get full text
Journal Article -
20
Progressive Improvement in Cutaneous and Extracutaneous Chronic Graft-versus-Host Disease after a 24-Week Course of Extracorporeal Photopheresis—Results of a Crossover Randomized Study
Published in Biology of blood and marrow transplantation (01-12-2011)“…In a prior multicenter randomized controlled trial, we found that a 12-week course of extracorporeal photopheresis (ECP) plus standard immunosuppressive…”
Get full text
Journal Article